Human Interleukin‐3 inhibits the binding of granulocyte‐macrophage colony‐stimulating factor and interleukin‐5 to basophils and strongly enhances their functional activity

Journal of Cellular Physiology

Volumn 145, Issue 1, 1990, Pages 69-77

  Lopez, Angel F ^a   Eglinton, Jeffrey M ^a   Lyons, A Bruce ^a   Tapley, Peter M ^a   To, Luen B ^a   Park, Linda S ^b   Clark, Steven C ^c   Vadas, Mathew A ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b AMGEN INC   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE; INTERLEUKIN 3; INTERLEUKIN 5; RADIOISOTOPE;

ARTICLE; BASOPHIL; CELL CULTURE; CONTROLLED STUDY; CYTOLOGY; HUMAN; HUMAN CELL; HYPERSENSITIVITY; PRIORITY JOURNAL;

BASOPHILS; BINDING, COMPETITIVE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTAMINE RELEASE; HUMAN; IN VITRO; INTERLEUKIN-3; INTERLEUKIN-5; IODINE RADIOISOTOPES; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTORS, INTERLEUKIN-3; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025007062     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.1041450111     Document Type: Article

References (40)

1. Comparative effect of recombinant IL‐1, ‐2, ‐3, ‐4, and ‐6, IFN‐γ granulocyte‐macrophage colony‐stimulating factor, tumor necrosis factor‐, and histamine releasing factors on the secretion of histamine from basophils
2. Platelet derived growth factor. II. Specific binding to culture cells
3. Measurement of specific radioactivities in labelled hormones by selfdisplacement analysis
4. Iodine monochloride (IC1) iodination techniques
5. Interleukin‐3 and granulocyte‐macrophage colony‐stimulating factor show common binding properties and biological effects on human monocytes
6. Interactions between receptors for interleukin 2 and interleukin 4 on lines of helper T cells (HT‐2) and B lymphoma cells (BLC1)
7. Purified human granulocyte‐macrophage colony‐stimulating factor: Direct action on neutrophils
8. Expression cloning of a receptor for human granulocyte‐macrophage colony‐stimulating factor
9. Specific binding, internalization, and degradation of human recombinant interleukin‐3 by cells of the acute myelogenous leukemia line, KG‐1
10. Human recombinant granulocyte‐macrophage colony‐stimulating factor and interleukin 3 cause basophil histamine release
11. Modulation of human basophil histamine release by hemopoietic growth factors
12. A short polypeptide marker sequence useful for recombinant protein identification and purification
13. Mechanism of passive sensitization. III Number of IgE molecules and their receptor sites on human basophil granulocytes
14. IL‐3‐dependent growth of basophil‐like cells and mastlike cells from human bone marrow
15. Interleukin 3‐dependent mediator release in basophils triggered by C5a
16. Synergism between interleukin‐6 and interleukin‐3 in supporting proliferation of human hemopoietic stem cells: comparison with interleukin‐1a
17. Activation of granulocyte cytotoxic function by purified mouse colony‐stimulating factors
18. Recombinant human interleukin‐5 (IL‐5) is a selective activator of human eosinophil function
19. Recombinant human interleukin‐3 stimulation of hematopoiesis in humans: Loss of responsiveness with differentiation in the neutrophilic myeloid series
20. Reciprocal inhibition of binding between interleukin‐3 and granulocyte‐macrophage colony‐stimulating factor to human eosinophils
21. Specific binding of human interleukin‐3 and granulocyte‐macrophage colony‐stimulating factor to human basophils
22. Keratinocyte‐Derived Interleukin 3
23. Recombinant IL‐3 induces histamine release from human basophils
24. The in vivo effects of recombinant human interleukin‐3: Demonstration of basophil differentiation factor, histamine‐producing activity and priming of GM‐CSF‐responsive progenitors in nonhuman primates
25. Heterogeneity in human interleukin‐3 receptors. A subclass that binds human granulocyte‐macrophage colony‐stimula ting factor
26. Characterization of the cell surface receptor for human granulocyte‐macrophage colony‐stimulating factor
27. Mast cell lines produce lymphokines in response to cross‐linkage of FcERI or to calcium ionophores
28. Histamine in human leucocytes. Localization of histamine and beta glucuronidase in human leucocytes
29. Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins
30. The attraction of proteins for small molecules and ions
31. Increased sensitivity of the enzymatic isotopic assay of histamine: Measurement of histamine in plasma and serum
32. Interleukin‐5 is at 5q31 and is deleted in the 5q‐syndrome
33. A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni
34. Activation of antibody‐dependent cell‐mediated cytotoxicity of human neutrophils and eosinophils by separate colony‐stimulating factors
35. Interleukin‐3 is a differentiation factor for human basophils
36. Interleukin 3 activates human blood basophils via high‐affinity binding sites
37. Molecular organisation of the cytokine gene cluster, involving the human IL‐3, IL‐4, IL‐5 and GM‐CSF genes, on human chromosome 5
38. Hierarchical down‐modulation of hemopoietic growth factor receptors
39. Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA enhancing factor and eosinophil colony‐stimulating activities: relationship to interleukin‐5